Humalog and Hip drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Hip (rose hip). Common drug interactions include nasopharyngitis among females and bronchitis among males.

The phase IV clinical study analyzes what interactions people have when they take Humalog and Hip. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

What is Hip?

Hip has active ingredients of rose hip. eHealthMe is studying from 473 Hip users. Check the latest studies of Hip.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

13 people who take Humalog and Hip together, and have interactions are studied.

What are the common drug interactions of Humalog and Hip, by gender? *:

female:

Nasopharyngitis (inflammation of the nasopharynx)
Viral upper respiratory tract infection
Asthenia (weakness)
Blood glucose increased
Eating disorder
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Mouth ulceration (mouth ulcers)
Swelling face

male:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Decreased immune responsiveness
Fatigue (feeling of tiredness)
Haemoglobin decreased
Joint injury
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pneumonia
White blood cell count decreased

What are the common drug interactions of Humalog and Hip, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Mouth ulceration (mouth ulcers)
Swelling face
Haemoglobin decreased
Headache (pain in head)
Joint injury
Nausea (feeling of having an urge to vomit)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pneumonia
White blood cell count decreased
Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

Sleep Disorder: 8 people, 61.54%
Muscle Spasms (muscle contraction): 8 people, 61.54%
Immune System Disorder: 8 people, 61.54%
Heart Transplant Rejection: 8 people, 61.54%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 1 person, 7.69%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 7.69%
Cushing's Syndrome (obesity, a rounded face, increased fat): 1 person, 7.69%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.69%
Breast Cancer: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog and Hip?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously